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Are oxidative stress markers helpful for diagnosing the
disease and determining its complexity or extent in
patients with stable coronary artery disease?
Oksidatif stres belirteçleri kararlı koroner arter hastalığının tanısında,
yaygınlığını ve kompleksliğini değerlendirmede yardımcı mıdır?
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Objective: The aim of this study was to investigate the re-
lationship between oxidative/antioxidative stress markers 
and the diagnosis and complexity of coronary artery disease 
(CAD) in patients with stable CAD.
Methods: A total of 145 patients were enrolled in the study. 
Based on coronary angiography results, the patients were 
categorized into 2 groups: those without CAD (Group 1) and 
those with CAD (Group 2). The patients in Group 2 were also 
categorized into low score and moderate/high score groups 
according to their SYNTAX score. The serum malondialde-
hyde (MDA) and total antioxidant capacity (TAOC) levels 
of Group 1 and Group 2 were compared. Finally, MDA and 
TAOC levels were compared between the moderate/high-risk 
and low-risk groups formed according to SYNTAX score.
Results: There was a significant difference with respect to 
both serum TAOC and MDA levels between Group 1 and 
Group 2 (p=0.036 and p=0.029, respectively). The groups 
with a SYNTAX score 1-22 and with a SYNTAX score >22 
were not significantly different with respect to serum TAOC or 
MDA level (p=0.582 and p=0.85, respectively).
Conclusion: The serum MDA level was significantly higher and 
the TAOC level was significantly lower in patients with stable 
CAD compared to those without; however, these molecule levels 
failed to predict disease complexity in patients with stable CAD.
Amaç: Bu çalışmanın amacı kararlı koroner arter hastalığı 
(KAH) olan hastalarda, hastalığın tanısında, kompleksitesi ve 
yaygınlığının değerlendirilmesinde serum oksidatif ve antiok-
sidatif stress belirteçlerinin yerinin olup olmadığının araştırıl-
masıdır.
Yöntemler: Çalışmaya toplam 145 hasta dahil edildi. Koro-
ner anjiyografi (KAG) sonuçlarına göre hastalar KAH’ı olma-
yan (grup 1) ve olan (grup 2) olmak üzere 2 gruba ayrıldı. 
Grup 2’deki hastalar SYNTAX skorlarına göre düşük skorlu 
ve orta-yüksek skorlu olmak üzere tekrar 2 gruba ayrıldı. 
Serum malondialdehit (MDA) ve total antioksidan kapasite-
si (TAK) seviyeleri hem grup 1 ve grup 2 arasında hem de 
düşük skorlu ve orta-yüksek skorlu gruplar arasında karşı-
laştırıldı.
Bulgular: Grup 1 ile grup 2’nin TAK ve MDA değerleri arasın-
da istatistiksel olarak anlamlı fark saptandı (sırasıyla, p=0.036 
ve p=0.029). SYNTAX skoru 1-22 olan grup ile SYNTAX skoru 
>22 olan grup arasında da TAK ve MDA seviyeleri yönünden 
istatistiksel olarak anlamlı fark bulunmadı (sırasıyla, p=0.582 
ve p=0.85).
Sonuç: Kararlı KAH olan hastalarda, KAH olmayanlara göre 
serum MDA seviyesi yüksek, TAK seviyesi ise düşüktür, ancak 
bu parametreler hastalığın kompleksitesi göstermede yeterli 
değildir.
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ABSTRACT ÖZET
ORIGINAL ARTICLE
Atherosclerotic cardiovascular disease (ASCVD) is a major global cause of death. Today, it ac-
counts for approximately 30% of deaths worldwide.
[1] Dyslipidemias, diabetes mellitus, hypertension, and 
smoking are contributors to the occurrence and pro-
gression of ASCVD.[2] It is well known that oxidative/
antioxidative parameters and inflammation play a criti-
cal role in pathophysiology of the atherosclerosis de-
velopment that leads to ASCVD.[3,4] Furthermore lipid 
abnormalities play a major role in the development of 
ASCVD. Studies have demonstrated that malondial-
dehyde (MDA) is an important marker of lipid per-
oxidation and that progression of atherosclerosis is 
correlated with oxidative stress and can be followed 
up using MDA.[5] Total antioxidant capacity (TAOC) 
is a global indicator of all antioxidants. This is a very 
useful parameter to show true antioxidant capacity.
[6] Although the relationship between oxidative stress 
and atherosclerosis is well known, the association 
between oxidative stress and stable coronary artery 
disease (CAD) complexity has not been clearly deter-
mined. Therefore, the aim of this study was to inves-
tigate the relationship between oxidative/antioxidative 
stress markers (MDA, TAOC) and the diagnosis and 
complexity of CAD in patients with stable CAD using 
Synergy between Percutaneous Coronary Intervention 
with TAXUS and Cardiac Surgery (SYNTAX) scores.
METHODS
Study population
This was a cross-sectional study. A total of 145 con-
secutive participants who underwent diagnostic coro-
nary angiography in the Baskent University, Ankara 
Hospital, Department of Cardiology from January 
2010 to July 2011 were evaluated. The indications 
for performing coronary angiography procedures 
were based on symptoms, risk factors, and results of 
appropriate noninvasive tests as per guidelines. The 
study was conducted in accordance with the guide-
lines proposed in the Declaration of Helsinki and was 
approved by the local ethics committee. Each patient 
provided a signed, informed consent form.
The following patients were excluded from the 
study: Patients who had cardiovascular disease (AS-
CVD, peripheral artery disease, cerebrovascular dis-
ease), renal disease (creatinine >1.5 mg/dL), patients 
with known malignancy, liver disease, active infection, 
allergy to contrast media, patients with unstable angi-
na or who required immediate percutaneous coronary 
intervention, and hemodynamically unstable patients.
In order to evaluate each patient’s serum MDA and 
TAOC levels, venous blood samples were taken 30 
minutes before coronary angiography.
Study design
In all, 145 patients who underwent coronary angiogra-
phy were enrolled in the study. Based on those results, 
the patients were 
categorized into 2 
groups: those with 
no CAD (Group 
1) and those with 
CAD (Group 2). 
Group 1 was similar 
to Group 2 in terms 
of clinical findings, 
demographics, and 
anthropometric measurements. SYNTAX scores were 
calculated for the patients in Group 2. Patients with 
CAD were further divided into 2 groups according 
to SYNTAX score (less complex: SYNTAX score 
1–22 and moderate/high complexity: SYNTAX score 
>22) as described in the European Society of Cardi-
ology (ESC) revascularization guideline.[7] First, se-
rum MDA and TAOC levels were compared between 
Group 1 and Group 2. Then, TAOC and MDA levels 
were compared between the moderate/high and low-
risk groups formed according to SYNTAX score.
Biochemical analysis
Serum TAOC measurement is generally based on the 
loss of the characteristic color of a stable 2,2’-azino-
bis (3-ethylbenz-thiazoline-6-sulfonic acid) radical 
cation through oxidation.[6] Serum MDA levels were 
determined using the spectrophotometric method at 
532 nm after boiling the sample and condensing it 
with thiobarbituric acid.[8] 
Coronary angiography imaging, intensity, and 
complexity of coronary artery disease
The indications for performing coronary angiography 
procedures were based on symptoms, risk factors, and 
the results of appropriate noninvasive tests accord-
ing to guidelines. A coronary angiographic examina-
tion was performed after the administration of local 
anesthesia, using the modified Seldinger technique 
through the femoral artery. All coronary arteries were 
visualized at right and left anterior oblique projec-
tions, with caudal and cranial angulations and left lat-
eral projection. 
The complexity of CAD was defined accord-
ing to SYNTAX score.[9] Each coronary lesion with 
a diameter stenosis of at least 50% and in vessels at 
least 1.5 mm was scored. The current online calcu-
lator (version 2.28; www.syntaxscore.com) was used 
to calculate the SYNTAX score.[10] An operator who 
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was blinded to other parameters calculated the scores 
based on angiographic findings.
Statistical analysis
Continuous variables were tested for normal distribu-
tion using the Kolmogorov-Smirnov test. Variables 
not normally distributed were expressed as medians 
(interquartile range). Normally distributed continuous 
variables were expressed as mean±SD. Categorical 
variables were summarized as frequency percent-
ages and absolute numbers. The means for normally 
distributed continuous variables were compared with 
the independent samples t-test. Continuous variables 
with non-normal distribution were analyzed using the 
Mann-Whitney U test. Chi-square test or Fisher’s ex-
act test was used to compare categorical variables as 
appropriate. The degree of association between con-
tinuous variables was evaluated using the Pearson or 
Spearman correlation test, as appropriate. Indepen-
dent determinants of variables were ascertained us-
ing standard multivariate logistic regression analysis. 
IBM SPSS Statistics for Windows, Version 21.0 (IBM 
Corp., Armonk, NY, USA) was used for all statistical 
calculations. P value <0.05 was considered statisti-
cally significant.
RESULTS
A total of 145 patients were included in the study. 
The baseline characteristics of the study population 
are shown in Table 1. According to the coronary angi-
ography results, CAD was absent in 43 (Group 1) of 
145 patients and present in 102 patients (Group 2). A 
comparison of the serum TAOC and MDA levels in 
Group 1 and Group 2 is illustrated in Figure 1. The 
serum TAOC level was 8.61±2.42 mM in Group 1 and 
7.47±3.16 mM in Group 2. There was a statistically 
significant difference between Group 1 and Group 
2 in terms of TAOC (p=0.036). Similarly, the serum 
MDA level was determined to be 6.65±1.30 nmol/L in 
Group 1 and 7.13±1.15 nmol/L in Group 2. There was 
Table 1. Baseline characteristics of the study population
 Non CAD group (n=43) CAD group (n=102) p
Age, years, Mean±SD 61.49±10.66 64.35±9.86 0.121
Male gender, n (%) 24 (55.8) 67 (65.7) 0.261
Body mass index (kg/m2), Mean±SD 29.21±4.41 28.73±4.12 0.143
Ejection fraction (%), Mean±SD 56.6±9.55 55.43±8.63 0.47
Hypertension, n (%) 42 (97.67) 100 (98.03) 1
Diabetes mellitus, n (%) 13 (30.23) 41 (40.19) 0.257
Hyperlipidemia, n (%) 19 (44.18) 55 (53.92) 0.284
Smokers, n (%) 11 (25.58) 38 (37.25) 0.175
Beta-blocker use, n (%) 43 (100) 102 (100) –
ACEI/ARB use, n (%) 22 (51.16) 49 (48.03) 0.731
Statin use, n (%) 18 (41.86) 56 (54.9) 0.151
Oral anti diabetic, n (%) 12 (27.96) 39 (38.23) 0.159
Insulin, n (%) 6 (13.95) 29 (28.43) 0.17
Creatinine (mg/dL), Mean±SD 0.79±0.23 0.86±0.21 0.131
Total cholesterol (mg/dL), Mean±SD 212.53±36.13 213.49±33.26 0.877
Low-density lipoprotein (mg/dL), Mean±SD 138.23±30.55 139.15±26.75 0.857
High-density lipoprotein (mg/dL), Mean±SD 47.16±12.58 47.19±11.08 0.991
Triglyceride, (mg/dL) 105 (70–140) 116 (87–146) 0.881
Hemoglobin (gr/dL), Mean±SD 14.09±1.4 13.72±1.42 0.155
White blood cell (/mm3), Mean±SD 8143±1369 8114±1470 0.913
Platelets (100/m3) 280 (230–340) 278 (256–296) 0.650
CAD: Coronary artery disease; ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; SD: Standard deviation.
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ity SYNTAX score >32. There was no significant dif-
ference between the less complex and moderate/high 
groups in terms of serum TAOC or MDA levels. The 
less complex group had TAOC level of 7.55±3.11 
mM and the moderate/high score group had a TAOC 
level of 7.12±3.4 mM (p=0.582). Similarly, the serum 
MDA level was found to be 7.12±1.14 nmol/L in the 
less complex group and 7.17±1.24 nmol/L in the mod-
erate/high SYNTAX score group (p=0.85).
Correlation analyses of clinical parameters (age, 
body mass index, creatinine, light-density lipoprotein, 
high-density lipoprotein, systolic blood pressure, fast-
a statistically significant difference between Group 1 
and Group 2 in terms of MDA (p=0.029).
A SYNTAX score was calculated for patients with 
CAD to determine CAD complexity. Patients with 
CAD were divided into less complex and moderate-
high complexity groups based on the SYNTAX score, 
according to the ESC revascularization guideline. Of 
102 patients with CAD, 80 (80.3%) were assessed to 
be in the less complex group (SYNTAX score 1–22) 
and 20 (19.6%) in the moderate/high group (SYN-
TAX score >22). Eighteen patients had a moderate 
SYNTAX score of 23-32 and 2 had high complex-
Figure 1. Comparison of serum TAOC and MDA levels between with and without CAD groups.
                  CAD: Coronary artery disease; MDA: Malondialdehyde; TAOC: Total antioxidant capacity.
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Table 2. Correlation analyses between some clinical parameters and serum total antioxidant 
capacity and malondialdehyde levels
 Total antioxidant capacity Malondialdehyde
Clinical variables r p r p
Age (years) -0.031 0.712 0.098 0.24
Body mass index (kg/m2) 0.022 0.792 0.1 0.232
Creatinine (mg/dL) 0.04 0.631 0.095 0.255
Low-density lipoprotein (mg/dL) 0.048 0.569 -0.086 0.306
High-density lipoprotein (mg/dL) 0.079 0.347 -0.027 0.745
Systolic blood pressure (mmHg) 0.126 0.131 0.053 0.528
Fasting plasma glucose (mg/dL) 0.12 0.151 -0.102 0.222
SYNTAX score -0.117 0.241 -0.03 0.765
SYNTAX: Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery trial.
ing plasma glucose, SYNTAX score) and TAOC, and 
MDA level revealed no statistical correlation between 
the parameters (p>0.05), as shown in Table 2.
Multivariate logistic regression analyses indicated 
that TAOC, male sex gender and hyperlipidemia were 
independent predictors of high SYNTAX score, as 
can be seen in Table 3.
DISCUSSION
In the present study, we explored whether serum oxi-
dative stress and antioxidative stress markers (MDA 
and TAOC) were helpful in making a diagnosis of 
CAD and whether they were predictors of the extent 
and complexity of CAD. The results revealed that al-
though serum MDA and TAOC levels were helpful 
in making a diagnosis of stable CAD, they were not 
beneficial in assessing the extent and complexity of 
CAD. The low overall SYNTAX score of the study 
participants may have affected the results.
Many studies to date have examined the role of the 
serum level of oxidant and antioxidant molecules in 
making the diagnosis of unstable CAD and assessing 
its extent and complexity; however, as discussed be-
low, their results varied greatly. In contrast to unstable 
CAD, no study yet has examined the level of these 
molecules in stable CAD. Therefore, our study is the 
first to contribute to the existing literature in this area. 
In biological organisms, some free oxygen radicals 
are derived from reactive oxygen species (ROS). In 
normal tissue, ROS are produced to a certain limit, 
and there is a delicate balance between oxidant and 
antioxidant molecules. When free radicals are pro-
duced in excessive amounts or the production of 
antioxidant molecules is inadequate, this balance is 
disrupted. This imbalance is called oxidative stress 
and plays an important role in the pathophysiology 
of atherosclerosis.[11] Atherosclerosis is a complex 
process of multifactorial origin. In addition to classi-
cal risk factors, oxidized LDL has an important role 
in the development and progression of atherosclero-
sis.[12] ROS can stimulate LDL oxidation. Oxidized 
LDL particles are modified lipoproteins internalized 
by macrophages. These cells are converted into fatty 
foam cells, the precursors of atherosclerosis, and the 
atherosclerotic process is begun.[13] Sigala et al. found 
a significantly higher tissue MDA level in atheroscle-
rotic carotid lesions compared with normal tissue, but 
could not relate this elevation to clinical presentation. 
They concluded that MDA is probably an important 
parameter in atherosclerosis development although 
it has no role in advanced stages of atherosclerosis 
and plaque rupture. In addition, the study found a 
significantly higher oxidized LDL level in unstable 
atherosclerotic carotid plaques compared with normal 
tissue.[14] Uno et al., in another study, found higher 
serum and tissue oxidized LDL levels in unstable ca-
rotid plaques and showed that this elevation was asso-
ciated with clinical findings.[15] MDA is an important 
enzyme for LDL oxidation. In another study by Turan 
et al., serum oxidative stress marker levels were cor-
related to Gensini score, but not to SYNTAX score 
in unstable CAD. The authors concluded that serum 
oxidative stress marker levels were predictive of dis-
ease extent, but not complexity, in patients with acute 
coronary syndrome.[16] Segev et al. found no correla-
tion between serum oxidized LDL level and angio-
graphic complexity in stable CAD. In addition, they 
concluded that the serum oxidized LDL level was not 
predictive of stent restenosis in patients with stable 
CAD.[17] Meuwissen et al. found levels of inflamma-
tory markers and amounts of oxidative substances 
to be significantly higher in atherectomy samples of 
patients with unstable CAD compared with those of 
stable CAD patients.[18] They concluded that inflam-
mation and oxidation may be responsible for plaque 
rupture and thrombosis in atherosclerosis.[18] In anoth-
er study, Sotoudeh et al. demonstrated that the level of 
TAOC was not found to be an independent predictor 
for the presence of CAD.[19] In addition to these stud-
ies, others have investigated the relationship between 
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Table 3. Independent predictors of SYNTAX score in 
multivariate logistic regression analysis
 β p
Total antioxidant capacity -0.168 0.033
Malondialdehyde 0.113 0.153
Age 0.041 0.608
Sex 0.155 0.047
Creatinine 0.139 0.079
Hypertension 0.078 0.326
Diabetes mellitus 0.004 0.963
Hyperlipidemia 0.337 <0.001
SYNTAX: Synergy between Percutaneous Coronary. Intervention with 
TAXUS and Cardiac Surgery trial.
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ety of Cardiology (ESC) and the European Association for 
Cardio-Thoracic Surgery (EACTS)Developed with the spe-
cial contribution of the European Association of Percuta-
neous Cardiovascular Interventions (EAPCI). Eur Heart J 
2014;35:2541–619. [CrossRef]
8. Satoh K. Serum lipid peroxide in cerebrovascular disorders 
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1978;90:37–43. [CrossRef]
9. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo 
A, Dawkins K, et al. The SYNTAX Score: an angiographic 
tool grading the complexity of coronary artery disease. Euro-
Intervention 2005;1:219–27.
10. SYNTAX working group. SYNTAX score calculator. Avail-
able at: www.syntaxscore.com. Accessed May 2017.
11. Förstermann U, Xia N, Li H. Roles of Vascular Oxidative 
Stress and Nitric Oxide in the Pathogenesis of Atherosclero-
sis. Circ Res 2017;120:713–35. [CrossRef]
12. Al Kasab S, Cassarly C, Le NA, Martin R, Brinley J, Chi-
mowitz MI, et al. Postprandial Clearance of Oxidized Low-
Density Lipoprotein in Patients with Stroke Due to Athero-
sclerosis. J Stroke Cerebrovasc Dis 2017;26:488–93.
13. Bian F, Cui J, Zheng T, Jin S. Reactive oxygen species mediate 
angiotensin II-induced transcytosis of low-density lipoprotein 
across endothelial cells. Int J Mol Med 2017;39:629–35. 
14. Sigala F, Kotsinas A, Savari P, Filis K, Markantonis S, Ilio-
dromitis EK, et al. Oxidized LDL in human carotid plaques is 
related to symptomatic carotid disease and lesion instability. J 
Vasc Surg 2010;52:704–13. [CrossRef]
15. Uno M, Kitazato KT, Suzue A, Itabe H, Hao L, Nagahiro S. 
Contribution of an imbalance between oxidant-antioxidant 
systems to plaque vulnerability in patients with carotid artery 
stenosis. J Neurosurg 2005;103:518–25. [CrossRef]
16. Turan T, Menteşe Ü, Ağaç MT, Akyüz AR, Kul S, Aykan AÇ, 
oxidative stress and CAD diagnosed by coronary 
computed tomography. Cho et al. reported that low 
total bilirubin and high gamma-glutamyltransferase 
levels were concomitantly associated with coronary 
atherosclerosis assessed by multidetector computed 
tomography.[20] In another study, it was shown that 
increased phagocytic nicotinamide adenine dinucle-
otide oxidase activity was associated with coronary 
artery calcification in asymptomatic men.[21] Their 
results were similar to and support our findings. Ac-
cording to the literature data, serum oxidative and an-
tioxidative substance markers may be responsible for 
instability and rupture of atherosclerotic plaques; they 
were, however, not helpful in determining the extent 
and complexity of stable atherosclerotic plaques.
Study limitations
Our study involved only patients with stable CAD, 
excluding patients with unstable CAD. Patients were 
using statins, which are known to exert antioxidant 
properties; thus, it is unknown to what degree statin 
use affected study results. Another limitation of the 
study is that the patients included had relatively low 
SYNTAX scores.
Conclusion
Serum MDA levels were significantly higher and 
TAOC levels were significantly lower in patients with 
stable CAD compared to those without; however, the 
level of these molecules failed to predict disease ex-
tent and complexity in patients with stable CAD.
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